Defining Resectability in Locally-Advanced Disease: Is the Line in the Eyes of the Beholder? [0.03%]
局部晚期疾病中可切除性的界定：是否存在“情人眼里出西施”？
Miriam Patella,Eleonora Maddalena Minerva,Bianca Battilana et al.
Miriam Patella et al.
Locally-advanced non-small cell lung cancer benefits from multimodal treatment approaches, with surgery playing a pivotal role. Advances in diagnostics and neoadjuvant therapies have increased complete resection rates and expanded surgical ...
Patient's Participation in Lung Cancer Surgical Treatment: The Role of Patient-Reported Outcomes and Advocacy [0.03%]
患者在肺癌手术治疗中的参与：患者报告结果和倡导的作用
Debora Brascia,Ilaria Potenza,Macarena Muto et al.
Debora Brascia et al.
Lung cancer significantly affects patients' physical health and emotional well-being, with survival rates remaining low despite advancements in treatment. While traditional clinical trials often overlook patient experiences, the focus is sh...
Stella T Tsui,Katherine D Gray
Stella T Tsui
Sublobar resection can be performed in selected patients with early stage nonsmall cell lung cancer with noninferior oncologic outcomes to lobectomy. Resection with surgical margins ≥2 cm or greater than the maximal tumor diameter, as well...
Introducing Innovations to Improve Lung Cancer Outcomes and Surgeon's Well-Being [0.03%]
创新改善肺癌治疗和外科医生福祉的方法
Ammara A Wakins,Rona Spector,Lana Y Schumacher
Ammara A Wakins
Lung cancer remains the leading cause of cancer-related mortality globally, underscoring the persistent need for transformative innovations in early detection and treatment modalities. We have come a long way in lung cancer treatment over t...
Present and Future of Non-palpable Pulmonary Lesion Localization Techniques [0.03%]
当前及未来肺非触诊病灶定位技术的发展与展望
Angela Maria Diaz,Stella Isabel Martínez,Carlos Andrés Carvajal
Angela Maria Diaz
This article reviews current and emerging techniques for localizing non-palpable pulmonary lesions, increasingly detected through advanced screening in early-stage lung cancer. Given the challenges of identifying small or sub-centimetric le...
Haley Tupper,Jane Yanagawa
Haley Tupper
Multiple lung nodules, ranging from nonsolid to pure solid, are common and can represent neoplastic and nonneoplastic etiologies. Among primary lung neoplasms, they can represent separate primary lung cancers (SPLCs) or intrapulmonary metas...
Michelle C Salazar,Aki Katarina Kobayashi
Michelle C Salazar
Lung cancer in never-smokers is a distinct clinical and molecular entity, with unique epidemiology, risk factors, and tumor biology. As smoking declines, the proportion of patients with lung cancer who have never smoked has increased. Women...
Camille Yongue,Sara Kryeziu,Lena Trager et al.
Camille Yongue et al.
Lung cancer remains the leading cause of cancer-related deaths, with increased incidental nodules and a higher incidence in young female individuals. Effective screening and evaluation are vital for early lung cancer detection, while advanc...
Defining Quality in Lung Cancer Surgery: Invasive Staging and Mediastinal Lymphadenectomy [0.03%]
肺癌手术质量的定义：淋巴结清扫和纵隔分期的重要性
Andrew Hawkins,Linda W Martin
Andrew Hawkins
Lung cancer remains the leading cause of cancer-related deaths worldwide with an overall 5 year survival rate of 27%. Global lung cancer cases are forecasted to increase 86.2% from 2.48 million in 2022 to 4.62 million in 2050. This rise ref...
Lillian L Tsai,Irmina A Elliott
Lillian L Tsai
Preoperative evaluation is crucial for ensuring optimal patient selection and minimizing surgical risk. Advances in surgical techniques, including minimally invasive procedures and sublobar resection, have broadened the pool of patients eli...